Biodexa Pharmaceuticals Plc (BDRX) stock
BDRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.14−0.10 (-4.46%)
Close on Nov 17, 2026Market cap $4.83MP/E –Yield –
Biodexa Pharmaceuticals operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
For fiscal 2025 it was -£5.59M. The highest annual figure on record is -£5.59M in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -£5.59M | – |
| FY2024 | Dec 31, 2024 | -£12.26M | – |
| FY2023 | Dec 31, 2023 | -£6.83M | – |
| FY2022 | Dec 31, 2022 | -£7.05M | – |
| FY2021 | Dec 31, 2021 | -£6.01M | – |
| FY2020 | Dec 31, 2020 | -£9.30M | – |
| FY2019 | Dec 31, 2019 | -£6.49M | – |
| FY2018 | Dec 31, 2018 | -£13.45M | – |
| FY2017 | Dec 31, 2017 | -£12.95M | – |
| FY2016 | Dec 31, 2016 | -£13.09M | – |
| FY2015 | Dec 31, 2015 | -£12.42M | – |
See a number that looks wrong?